Clinical Strategies for Oral Implant Restoration in Patients with Sjögren's Syndrome

doi:10.12337/zgkqjxjyzz.2023.04.002

Chinese Journal of Stomatological Continuing Education ›› 2023, Vol. 26 ›› Issue (4): 240-246.DOI: 10.12337/zgkqjxjyzz.2023.04.002

Previous Articles Next Articles

Clinical Strategies for Oral Implant Restoration in Patients with Sjögren's Syndrome

Haixia Xing, Lin Wang, Jie Pan, Yu Kong^*

Department of General Dentistry, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, P,R. China

Online:2023-07-31 Published:2023-11-29
Contact: Yu Kong. Tel: 010-82195586. Email: amalgam6@sina.com. Address: No.22, Zhongguancun South Avenue, Haidian District, Beijing 100081, P.R. China
Supported by:
National Science Foundation of China(No.51801003)

Abstract

Abstract: Sjögren's syndrome (SS) is a systemic autoimmune disease with typical clinical symptoms such as dry mouth, dry eyes, and joint pain. Patients suffering from SS might be accompanied by systemic symptoms and had to take kinds of anti-rheumatic drugs for a long time. This condition might affect the treatment of dental implant restoration. As the increasing requirements for quality of life, SS patients' demand for dental implant restoration also increased. Whether dental implant restoration is feasible for SS patients, how to choose the appropriate timing for dental implants, and how to maintain the restoration effect have become difficult problems for dentists. Currently, there are no relevant treatment guidelines or expert consensus on dental implant restoration for SS patients. Based on our team's years of experience in the diagnosis and treatment of oral diseases in patients with SS, especially in dental implant restorations, the authors reviewed relevant research, in order to provide clinical suggestions for the stomatologists.

Key words: Sjögren's syndrome, dental implant, anti-rheumatic drugs, partial edentulous arch, edentulous arch

Haixia Xing, Lin Wang, Jie Pan, Yu Kong. Clinical Strategies for Oral Implant Restoration in Patients with Sjögren's Syndrome[J]. Chinese Journal of Stomatological Continuing Education, 2023, 26(4): 240-246.

References

[1] Mariette X, Criswell LA.Primary Sjögren's Syndrome[J]. N Engl J Med. 2018; 378(10):931-939.
[2] Patel R, Shahane A.The epidemiology of Sjögren's syndrome[J]. Clin Epidemiol. 2014; 6: 247-255.
[3] Chuang CJ, Hsu CW, Lu MC, et al.Increased risk of developing dental diseases in patients with primary Sjögren's syndrome-A secondary cohort analysis of population-based claims data[J]. PLoS One. 2020; 15(9):e0239442.
[4] Maarse F, Jager DH, Forouzanfar T, et al.Tooth loss in Sjögren's syndrome patients compared to age and gender matched controls[J]. Med Oral Patol Oral Cir Bucal. 2018; 23(5):e545-e551.
[5] Tanaka A, Kellesarian SV, Arany S.Xerostomia and patients' satisfaction with removable denture performance: systematic review[J]. Quintessence Int. 2021; 52(1):46-55.
[6] Mori G, Kobayashi T, Ito T, et al.Implant-supported Prostheses in Patient with Sjögren's Syndrome: Clinical Report with 3-year Follow-up[J]. Bull Tokyo Dent Coll. 2018; 59(3):201-206.
[7] Wei W, Ahmad SS, Chi S, et al.From Molecular Mechanism to the Etiology of Sjögren's Syndrome[J]. Curr Pharm Des. 2018; 24(35):4177-4185.
[8] 刘伟, 宋慧, 董鹏. 骨免疫学研究进展[J]. 骨科临床与研究杂志, 2020, 5(2):124-126.
[9] Carcuac O, Berglundh T.Composition of human peri-implantitis and periodontitis lesions[J]. J Dent Res. 2014; 93(11):1083-1088.
[10] Barros AWP, Sales PHDH, Carvalho AAT, et al.Is Sjögren's syndrome a risk factor/contraindication for dental implants? An umbrella review[J]. Spec Care Dentist. 2021; 41(4):453-462.
[11] In ‘t Veld M, Schulten EAJM, Neveling U, et al. A Novel Approach for Immediate Implant-based Oral Rehabilitation in a Sjögren's Syndrome Patient Using Virtual Surgical and Prosthetic Planning[J]. J Oral Implantol. 2022; 48(2):139-146.
[12] Chrcanovic BR, Kisch J, Wennerberg A.Dental implants in patients with Sjögren's syndrome: a case series and a systematic review[J]. Int J Oral Maxillofac Surg. 2019; 48(9):1250-1259.
[13] Turkyilmaz I, Unsal GS.Full-mouth rehabilitation of an elderly patient with Sjögren's syndrome by using implant-supported fixed dental prostheses including CAD/CAM frameworks[J]. J Dent Sci. 2019; 14(4): 428-429.
[14] Korfage A, Raghoebar GM, Arends S, et al.Dental Implants in Patients with Sjögren's Syndrome[J]. Clin Implant Dent Relat Res. 2016; 18(5):937-945.
[15] Albrecht K, Callhoff J, Westhoff G, et al.The Prevalence of Dental Implants and Related Factors in Patients with Sjögren Syndrome Results from a Cohort Study[J]. J Rheumatol. 2016; 43(7):1380-1385.
[16] Howe MS, Keys W, Richards D.Long-term(10-year) dental implant survival: A systematic review and sensitivity meta-analysis[J]. J Dent. 2019; 84:9-21.
[17] Maarse F, Fennis WMM, Twisk JWR, et al.Dental implants in dentate primary and secondary Sjögren's syndrome patients: A multicenter prospective cohort study[J]. Clin Oral Implants Res. 2022; 33(11):1157-1170.
[18] Carr AB, Revuru VS, Lohse CM.Association of Systemic Conditions with Dental Implant Failures in 6, 384 Patients During a 31-Year Follow-up Period[J]. Int J Oral Maxillofac Implants. 2017; 32(5):1153-1161.
[19] 张文, 厉小梅, 徐东, 等. 原发性干燥综合征诊疗规范[J]. 中华内科杂志, 2020, 59(4):269-276.
[20] 王倩, 戴生明. 《2019年欧洲抗风湿病联盟干燥综合征局部与系统性治疗推荐》解读[J]. 中华临床免疫和变态反应杂志, 2020, 14(3):179-182.
[21] Ramos-Casals M, Brito-Zerón P, Bombardieri S, et al.EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies[J]. Ann Rheum Dis. 2020; 79(1):3-18.
[22] Skarlis C, Marketos N, Mavragani CP.Biologics in Sjögren's syndrome[J]. Pharmacol Res. 2019; 147: 104389.
[23] Kuo PI, Lin TM, Chang YS, et al.Primary Sjögren's syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw[J]. Sci Rep. 2021; 11(1):1612.
[24] de Mendonça Invernici M, Finger Stadler A, Vale Nicolau G, et al. Management of Sjögren's Syndrome Patient: A Case Report of Prosthetic Rehabilitation with 6-Year Follow-Up[J]. Case Rep Dent. 2014; 2014: 761251.
[25] Compston J.Glucocorticoid-induced osteoporosis: an update[J]. Endocrine. 2018; 61(1):7-16.
[26] Lane NE.Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments[J]. Curr Osteoporos Rep. 2019; 17(1):1-7.
[27] Goodman SM, Springer BD, Chen AF, et al.2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty[J]. Arthritis Care Res (Hoboken). 2022; 74(9):1399-1408.
[28] Ruggiero SL, Dodson TB, Aghaloo T, et al.American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update[J]. J Oral Maxillofac Surg. 2022; 80(5):920-943.
[29] Chochlidakis K, Ercoli C, Elad S.Challenges in implant-supported dental treatment in patients with Sjögren's syndrome: A case report and literature review[J]. Quintessence Int. 2016; 47(6):515-524.
[30] Chappuis V, Avila-Ortiz G, Araújo MG, et al.Medication-related dental implant failure: Systematic review and meta-analysis[J]. Clin Oral Implants Res. 2018; 29(Suppl 16):55-68.
[31] Sher J, Kirkham-Ali K, Luo JD, et al.Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review[J]. J Oral Implantol. 2021; 47(3):249-268.
[32] Stavropoulos A, Bertl K, Pietschmann P, et al.The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis[J]. Clin Oral Implants Res. 2018; 29(Suppl 18):54-92.
[33] Granate-Marques A, Polis-Yanes C, Seminario-Amez M, et al.Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: Systematic review[J]. Med Oral Patol Oral Cir Bucal. 2019; 24(2):e195-e203.
[34] 林野, 邸萍.口腔种植学[M].第2版.北京:北京大学医学出版社, 2021:44.
[35] Luo JD, Miller C, Jirjis T, et al.The effect of non-steroidal anti-inflammatory drugs on the osteogenic activity in osseointegration: a systematic review[J]. Int J Implant Dent. 2018; 4(1):30.
[36] 邢海霞, 王琳, 乔迪, 等. 干燥综合征口腔疾病的治疗特点[J/OL]. 北京大学学报(医学版), 2022, (2022-02-28, 网络首发), 网址: https://kns.cnki.net/kcms/detail/11.4691.R. 20220225.1800.018.html
[37] Sherrell W, Desai B, Sollecito TP.Dental Considerations in Patients with Oral Mucosal Diseases[J]. Dermatol Clin. 2020; 38(4):535-541.
[38] 周培茹, 蒋析, 华红. 口腔黏膜病患者口腔种植的时机及注意事项[J]. 北京大学学报 (医学版 ), 2021, 53(1):5-8.
[39] Makowiecki A, Hadzik J, Błaszczyszyn A, et al.An evaluation of superhydrophilic surfaces of dental implants-a systematic review and meta-analysis[J]. BMC Oral Health. 2019; 19(1):79.
[40] Albrektsson T, Wennerberg A. On osseointegration in relation to implant surfaces[J]. Clin Implant Dent Relat Res.2019; 21 Suppl 1:4-7.
[41] Strietzel FP, Schmidt-Westhausen AM, Neumann K, et al.Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases-A systematic review[J]. Med Oral Patol Oral Cir Bucal. 2019; 24(2): e217-e230.
[42] Almeida D, Vianna K, Arriaga P, et al.Dental implants in Sjögren's syndrome patients: A systematic review[J]. PloS One. 2017; 12(12):e0189507.
[43] 冯璐, 孟文霞. 常见口腔黏膜疾病患者行种植修复相关问题的研究进展[J]. 国际口腔医学杂志, 2021, 48(2):147-155.
[44] Esimekara JO, Perez A, Courvoisier DS, et al.Dental implants in patients suffering from autoimmune diseases: A systematic critical review[J]. J Stomatol Oral Maxillofac Surg. 2022; 123(5):e464-e473.

Clinical Strategies for Oral Implant Restoration in Patients with Sjögren's Syndrome

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 1

Recommended Articles

Metrics

Comments